A systematic review of immune-related adverse event reporting in clinical trials of immune checkpoint inhibitors
Chen, T.W., Razak, A.R., Bedard, P.L., Siu, L.L., Hansen, A.R.
Published in Annals of oncology (01.09.2015)
Published in Annals of oncology (01.09.2015)
Get full text
Journal Article
Real-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium
Stukalin, I, Wells, J C, Graham, J, Yuasa, T, Beuselinck, B, Kollmansberger, C, Ernst, D S, Agarwal, N, Le, T, Donskov, F, Hansen, A R, Bjarnason, G A, Srinivas, S, Wood, L A, Alva, A S, Kanesvaran, R, Fu, S Y F, Davis, I D, Choueiri, T K, Heng, D Y C
Published in Current oncology (Toronto) (01.04.2019)
Published in Current oncology (Toronto) (01.04.2019)
Get full text
Journal Article
2863 A comparison of weekly versus 3-weekly cisplatin during adjuvant radiotherapy for high-risk head and neck cancer
Oosting, S.F, Chen, T.W.W, Huang, S.H.H, Wang, L, Waldron, J, Gilbert, R, Goldstein, D.P, Halmos, G.B, Witjes, M.J.H, Gietema, J.A, O'Sullivan, B, Langendijk, J.A, Siu, L.L, Hansen, A.R
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review
Khoja, L., Day, D., Wei-Wu Chen, T., Siu, L.L., Hansen, A.R.
Published in Annals of oncology (01.10.2017)
Published in Annals of oncology (01.10.2017)
Get full text
Journal Article
Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study
Hansen, A.R., Massard, C., Ott, P.A., Haas, N.B., Lopez, J.S., Ejadi, S., Wallmark, J.M., Keam, B., Delord, J.-P., Aggarwal, R., Gould, M., Yang, P., Keefe, S.M., Piha-Paul, S.A.
Published in Annals of oncology (01.08.2018)
Published in Annals of oncology (01.08.2018)
Get full text
Journal Article
1005P Microbial ecosystem therapeutics 4 (MET4) treatment mediates a humoral response in patients treated with immune checkpoint inhibition (ICI)
Spiliopoulou, P., Wong, M., Boukhaled, G.M., Gadalla, R., Strum, S., Liu, R., Heirali, A., Wang, B.X., Saibil, S., Hansen, A.R., Siu, L.L., Coburn, B., Spreafico, A.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
3P Beyond first-line therapy in metastatic adrenal cortical cancer (ACC): Is it time to move on from chemotherapy?
Mittal, A., Amer, L., Ayodele, O., Radi, S., Li, X., Mete, O., Pasternak, J., Jiang, D.M., Kumar, V., Hansen, A.R.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1664MO Tumor-naïve methylomes and fragmentomes during pembrolizumab (P) in metastatic cancer patients
Zhao, E.Y., Sanz Garcia, E., Liu, Z., Marsh, K., Abdul Razak, A., Spreafico, A., Bedard, P.L., Hansen, A.R., Lheureux, S., Torti, D., Lam, B., Pugh, T.J., Siu, L.L.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1754P Association between body mass index (BMI) and anti-PD1/L1 immune checkpoint inhibitor (ICI) outcomes in patients with metastatic urothelial carcinoma (mUC)
Labidi, S., N. Meti, R. Barua, Riromar, J.J., Hansen, A.R., Jiang, D.M., Fallah-Rad, N., Sridhar, S., Ferrario, C., Pezo, R., Cheng, S., Sacher, A., Rose, A.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
114P Changes in serum choline (Ch) levels to predict treatment outcomes in advanced cancer patients (pts) treated with immunotherapy (IO)
Garcia, E. Sanz, Genta, S., Liu, Z., Razak, A.R. Abdul, Hansen, A.R., Spreafico, A., Zhang, W., Chen, E., Siu, L.L., Bedard, P.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
541P Ezabenlimab (BI 754091), an anti-PD-1 antibody, in combination with BI 836880, a VEGF/Ang2-blocking nanobody, in patients (pts) with previously treated advanced solid tumours
Hussein, M., Percent, I., Arrowsmith, E., Arkenau, H-T., Chu, Q., Hansen, A.R., Erzen, D., Qiu, S., Lucarelli, A., Ulahannan, S.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
LBA65 Efficacy of 177Lu-PNT2002 in PSMA-positive mCRPC following progression on an androgen-receptor pathway inhibitor (ARPI) (SPLASH)
Sartor, O., Jiang, D.M., Smoragiewicz, M., Zibelman, M., Flechon, A., El-Haddad, G., Abikhzer, G., Saad, F., Tutrone, R., Tagawa, S.T., Metser, U., Calais, J., Hansen, A.R., Wu, W., Jensen, J., Trieu, C.R., Fleshner, N., Teslenko, I., Provost, J-C.G., Chi, K.N.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
First-in-class Microbial Ecosystem Therapeutic 4 (MET4) in combination with immune checkpoint inhibitors in patients with advanced solid tumors (MET4-IO trial)
Spreafico, A., Heirali, A.A., Araujo, D.V., Tan, T.J., Oliva, M., Schneeberger, P.H.H., Chen, B., Wong, M.K., Stayner, L.-A., Hansen, A.R., Saibil, S.D., Wang, B.X., Cochrane, K., Sherriff, K., Allen-Vercoe, E., Xu, W., Siu, L.L., Coburn, B.
Published in Annals of oncology (01.06.2023)
Published in Annals of oncology (01.06.2023)
Get full text
Journal Article
1455P Characterization of patients with metastatic renal cell carcinoma achieving complete response to first-line therapies: Results from the international metastatic renal cell carcinoma database consortium (IMDC)
Takemura, K., Navani, V., Ernst, M.S., Wells, J.C., Choueiri, T.K., Meza, L., Pal, S.K., Lee, J-L., Li, H., Agarwal, N., Alva, A.S., Hansen, A.R., Basappa, N.S., Szabados, B.E., Powles, T.B., Tran, B., Hocking, C.M., Beuselinck, B., Yuasa, T., Heng, D.Y.C.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
546P Pembrolizumab for microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) advanced endometrial cancer: Long-term follow-up results from KEYNOTE-158
O'Malley, D., Bariani, G.M., Cassier, P.A., Marabelle, A., Hansen, A.R., De Jesus-Acosta, A., Miller, W.H., Safra, T., Italiano, A., Mileshkin, L., Yao, L., Gozman, A., Jin, F.J., Maio, M.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1367P JNJ-70218902 (JNJ-902), a TMEFF2 x CD3 bispecific antibody, in prostate cancer: Initial results from a phase I dose escalation study
Calvo, E., Doger de Spéville, B., Carles Galceran, J., Peer, A., Sarid, D.L., Eigl, B.J., Avadhani, A., Yao, D., Lin, V., Wu, S., Jaiprasart, P., Loffredo, J., Tamegnon, M., Xie, H., Hansen, A.R.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1400P Efficacy and safety of 177Lu-PNT2002 prostate-specific membrane antigen (PSMA) therapy in metastatic castration resistant prostate cancer (mCRPC): Initial results from SPLASH
Hansen, A.R., Probst, S., Tutrone, R.F., Osman, M.M., Delpassand, E.S., Nordquist, L.T., Viglianti, B.L., Michalski, J.M., Beauregard, J-M., Oz, O.K., Courtney, K., Jensen, J., Wu, W., Fleshner, N., Sartor, O., Chi, K.N., Tagawa, S.T.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1755PD - Implementation of PRO-CTCAE in phase I clinical trials identifies under reporting of adverse events
Veitch, Z.W., Shepshelovich, D., Gallagher, C., Wang, L., Razak, A.A., Spreafico, A., Bedard, P., Siu, L.L., Minasian, L., Hansen, A.R.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Results from a randomised phase I/II trial evaluating the safety and antitumour activity of anti-PD-1 (MEDI0680)/anti-PD-L1 (durvalumab) vs anti-PD-1 (nivolumab) alone in metastatic clear cell renal cell carcinoma (ccRCC)
Voss, M.H., Azad, A.A., Hansen, A.R., Gray, J.E., Welsh, S.J., Achour, I., Hu, H., Lewis, L., Walcott, F.L., Oosting, S.F.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Implementation of PRO-CTCAE in phase I clinical trials identifies under reporting of adverse events
Veitch, Z.W., Shepshelovich, D., Gallagher, C., Wang, L., Razak, A.A., Spreafico, A., Bedard, P., Siu, L.L., Minasian, L., Hansen, A.R.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article